ReleaseWire Connect

IR Diagnostyx Inc. (IR Diagnostyx) is a pharmaceutical and healthcare company, based in the US. It specializes in providing rapid, accurate, and painless disease diagnosis for functional diseases such as irritable bowel syndrome, interstitial cystitis/painful bladder syndrome, fibromyalgia, and chronic fatigue syndrome. The company offers its services to regional medical and educational institutions and also for further studies for the other diseases. IR Diagnostyx was started through the Technology Entrepreneurship and commercialization institute at the Fisher College of Business. The company has set up a central CLIA certified lab in Columbus, Ohio to launch its operations. IR Diagnostyx is headquartered in Columbus, Ohio, the US.

General Electric Company (GE), a diversified company, agreed to acquire 15% stake in XD Electric Co., Ltd., a manufacturer of electricity transmission and distribution equipment, for a purchase consideration of approximately CNY3,380m ($533.94m). The acquisition will enable GE to enhance its ability to provide end-to-end transmission and distribution solutions, and to expand its market presence in China. The acquisition will give the company the ability to harness the growth potential offered by China's T&D industry, and will enhance the revenues of the company in the long run.

We expect the Japanese mining industry to reach US$9.99bn in value by 2016, an annual average growth rate of only slightly more than 1.0% from 2011 levels. The country has practically little to no mineral resources, hence our view of slow growth for the industry. That said, the country has some production potential in industrial minerals, such as dolomite, silica sands, silica stone and limestone. Of note is the country's 40.4 billion tonnes (bnt) of limestone reserves. Japan is also a very minor gold producer (2011 production of 279,000 ounces).

Central to "ambient intelligence"; insights into the wireless sensors market for precision agriculture and environmental monitoring are detailed in this report. This report refers to environmental and agricultural monitoring as areas deployed with intelligent sensor interface that tracks, informs about, provides granular control of, and monitors the environment and agriculture in situ- real time.

The 220 drugs in the non-small cell lung cancer (NSCLC) pipeline, is dominated by targeted therapies across all stages. There are a growing number of immunotherapies in development as drug developers look to target mutations and tumor specific antigens.

The dental equipment market consists of devices used in diagnosing dental diseases/conditions and treating the same. These include dental chairs, hand pieces, CAD/CAM systems, scaling units, instrument delivery systems, dental lasers, intra oral and extra oral radiology equipment, and CBCT scanners. The global market for these equipment was valued at $4.5 billion in 2011 and is expected to grow at a CAGR of 5.8% from 2011 to 2016.

With ingredient companies facing many issues, such as the economy, the environment and increased competition, the ability of companies to grow their businesses is becoming even tougher. However, ingredient companies are employing a wide range of business strategies to increase revenue and profit. These issues and the strategies used to counteract them are discussed in this report, and are illustrated with case studies showing how ingredient companies are implementing them into their businesses.

While it is still early days for mobile payments, a number of factors, such as a rapid rise in smartphone adoption, as well as government and corporate initiatives, have created a lot of buzz around this topic. This report will look at the new mobile frontier, the stakeholders that make up this vast ecosystem, how approaches differ across market types, and which countries are likely to be the first to reach mass adoption.